Radonjić, Nevena V. http://orcid.org/0000-0002-1272-2284
Hess, Jonathan L. http://orcid.org/0000-0001-8406-632X
Rovira, Paula http://orcid.org/0000-0003-2177-8412
Andreassen, Ole
Buitelaar, Jan K. http://orcid.org/0000-0001-8288-7757
Ching, Christopher R. K.
Franke, Barbara http://orcid.org/0000-0003-4375-6572
Hoogman, Martine
Jahanshad, Neda http://orcid.org/0000-0003-4401-8950
McDonald, Carrie
Schmaal, Lianne http://orcid.org/0000-0001-9822-048X
Sisodiya, Sanjay M.
Stein, Dan J. http://orcid.org/0000-0001-7218-7810
van den Heuvel, Odile A.
van Erp, Theo G. M. http://orcid.org/0000-0002-2465-2797
van Rooij, Daan
Veltman, Dick J.
Thompson, Paul
Faraone, Stephen V. http://orcid.org/0000-0002-9217-3982
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (667302, 667302, 667302, 667302, 667302, 667302, 667302, 667302, 667302, 667302, 667302, 667302, 667302)
Article History
Received: 29 May 2020
Revised: 7 December 2020
Accepted: 11 December 2020
First Online: 17 January 2021
Compliance with ethical standards
:
: OA has received speaker’s honorarium from Lundbeck and is a consultant to HealthLytix. In the past year, SVF received income, potential income, travel expenses continuing education support, and/or research support from Tris, Otsuka, Arbor, Ironshore, Shire, Akili Interactive Labs, Enzymotec, Sunovion, Supernus and Genomind. With his institution, he has US patent US20130217707 A1 for the use of sodium–hydrogen exchange inhibitors in the treatment of ADHD. He also receives royalties from books published by Guilford Press: Straight Talk about Your Child’s Mental Health, Oxford University Press: Schizophrenia: The Facts and Elsevier: ADHD: Non-Pharmacologic Interventions. He is Program Director of ExternalRef removed. BF received educational speaking fees from Medice. All other authors declare no conflict of interest.